Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Berruezo Llacuna, Maria (1) Birchmeier, Walter Prof. Dr. (1) Dahlmann, Mathias Dr. (3) Daniel, Peter Prof. Dr. (3) Di Virgilio, Michela Prof. Dr. (1) Driesner, Madlen (1) Graf, Robin Dr. (2) Hinz, Michael Dr. (1) Höpken, Uta Elisabeth PD Dr. (1) Keller, Lisa (1) Keller, Ulrich Dr. med. (2) Kobelt, Dennis Dr. (6) Kocks, Christine Dr. (1) Leutz, Achim Prof. Dr. (1) Mathas, Stephan Dr. (7) Mertins, Philipp Dr. (1) Popp, Oliver Dr. (1) Prigione, Alessandro Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rehm, Armin Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (55) Smith, Janice (2) Stein, Ulrike Prof. Dr. (20) Walther, Wolfgang Prof. Dr. (13) Wollert-Wulf, Brigitte (2) (-) Janz, Martin Dr. (11) (-) Lusatis, Simone (1) Bioinformatics and Omics Data Science (1) (-) Biologie maligner Lymphome (11) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Genomdiversifikation & Integrität (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Proteom Dynamik (9) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) RNA Biologie und Posttranscriptionale Regulation (1) (-) Translationale Onkologie solider Tumore (1) Translationale Tumorimmunologie (1) 1999 (1) 2000 (1) 2002 (1) (-) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (4) 2007 (2) 2008 (2) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (1) 2015 (2) 2016 (1) 2017 (3) 2018 (1) 2019 (1) (-) 2020 (4) 2021 (3) 2022 (4) 2023 (6) 2024 (1) 11 Ergebnisse: Active Filter: Janz, Martin Dr.Lusatis, SimoneBiologie maligner LymphomeTranslationale Onkologie solider Tumore200320062020 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Januar 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer 01. August 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken 01. Mai 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara 01. Oktober 2020 / Invest New Drugs Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma F. Kroschinsky J.M. Middeke M. Janz G. Lenz M. Witzens-Harig R. Bouabdallah P. La Rosée A. Viardot G. Salles S.J. Kim T.M. Kim O. Ottmann J. Chromik A.M. Quinson U. von Wangenheim U. Burkard A. Berk N. Schmitz 06. Juli 2020 / J Exp Med Restriction of memory B cell differentiation at the germinal center B cell positive selection stage A. Toboso-Navasa A. Gunawan G. Morlino R. Nakagawa A. Taddei D. Damry Y. Patel P. Chakravarty M. Janz G. Kassiotis R. Brink M. Eilers D.P. Calado 05. Oktober 2020 / J Exp Med PDGFA-associated protein 1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification V. Delgado-Benito M. Berruezo-Llacuna R. Altwasser W. Winkler D. Sundaravinayagam S. Balasubramanian M. Caganova R. Graf A. Rahjouei M.T. Henke M. Driesner L. Keller A. Prigione M. Janz A. Akalin M. Di Virgilio Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Januar 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer
01. August 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken
01. Mai 2003 / Blood Macrophage inflammatory protein 1-alpha (MIP-1alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells S. Lentzsch M. Gries M. Janz R. Bargou B. Doerken M.Y. Mapara
01. Oktober 2020 / Invest New Drugs Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma F. Kroschinsky J.M. Middeke M. Janz G. Lenz M. Witzens-Harig R. Bouabdallah P. La Rosée A. Viardot G. Salles S.J. Kim T.M. Kim O. Ottmann J. Chromik A.M. Quinson U. von Wangenheim U. Burkard A. Berk N. Schmitz
06. Juli 2020 / J Exp Med Restriction of memory B cell differentiation at the germinal center B cell positive selection stage A. Toboso-Navasa A. Gunawan G. Morlino R. Nakagawa A. Taddei D. Damry Y. Patel P. Chakravarty M. Janz G. Kassiotis R. Brink M. Eilers D.P. Calado
05. Oktober 2020 / J Exp Med PDGFA-associated protein 1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification V. Delgado-Benito M. Berruezo-Llacuna R. Altwasser W. Winkler D. Sundaravinayagam S. Balasubramanian M. Caganova R. Graf A. Rahjouei M.T. Henke M. Driesner L. Keller A. Prigione M. Janz A. Akalin M. Di Virgilio